Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy

NCT01508468 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Membranous Nephropathy

Interventions

DRUG: symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
DRUG: experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)

Sponsor

Assistance Publique - Hôpitaux de Paris